Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues

<div>Bar graph showing the rate of major clinical events in clinical trials comparing 12-month dual antiplatelet strategy (DAPT) vs. a shorter strategy followed by ticagrelor alone.</div>

Cardiovascular Therapeutics

fig2

Figure 2

Figure 2: Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues 